Founding Director of RAS Life Science Solutions Aditya Bahl Vancouver, British Columbia--(Newsfile Corp. - March 15, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce the appointment of Aditya Bahl as an advisor and consultant for the Company.
Mr. Bahl brings over 20 years of experience in pharmaceutical marketing and clinical development. He is the CEO and founder of RAS LSS, a boutique healthcare consulting group based in Germany. He provides strategic guidance to biotechnology and pharmaceutical companies on franchise/product strategy, clinical development and commercialization.
Mr. Bahl, who worked as Director of Competitive Intelligence at Novartis Pharma AG and as Senior Consultant for Janssen Research and Development, is known for his entrepreneurship, creativity and is a passionate speaker for innovations in healthcare. He has significant leadership experience across several therapeutic areas, including oncology and biosimilars.
Mr. Stephen Van Deventer, PreveCeutical's Chief Executive Officer, commented, "We are thrilled to have Mr. Bahl work with us, in particular at this stage, as we are actively working on development, clinical trials, and commercialization of our products. His strategic guidance will be invaluable for our Company's success."
Aditya Bahl commented, "Supporting PreveCeutical to bring them to the clinical trial and commercialization phase aligns perfectly with my own mission of reducing healthcare burden by supporting the development and commercialization of innovative pharmacological technologies."
About RAS Life Sciences Solutions
Starting with Information Services in 2014, RAS Life Sciences Solutions has evolved into a boutique healthcare consulting group. They offer a niche portfolio of Strategy Support and Information Services to Pharmaceutical and Medical Device Companies throughout the product lifecycle.
RAS LSS elucidates and contextualizes current and future market complexities. Leveraging their collective intelligence, they strive to help clients succeed via best-in-class situation analysis and competitively differentiated strategy.
About PreveCeutical
PreveCeutical is a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature identical products. The Company aims to be a leader in the preventive health sciences sector.
With the completion of three of its research programs, the Company is actively working on the clinical development, and commercialization of its products; and has filed a number of provisional patent applications to protect the intellectual property from its research programs.
For more information about PreveCeutical, please visit our website www.PreveCeutical.com or follow us on Twitter and Facebook.
On behalf of the Board of Directors of PreveCeutical
Stephen Van Deventer, Chairman and Chief Executive Officer
For further information, please contact:
Stephen Van Deventer: +1 604 306 9669
Or Investor Relations ir@preveceutical.com